Evidence map›Paper›PMID 39043423›Full record

ArticleRespiratory care2024

Rehabilitation Is Associated With Improvements in Post-COVID-19 Sequelae.

Andreas Asimakos, Stavroula Spetsioti, Spyros Mentzelopoulos, Ioannis Vogiatzis, Alice G Vassiliou, Pantelis Gounopoulos, Archontoula Antonoglou, Dimitrios Spaggoulakis, Sofia Pappa, Spyros Zakynthinos and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Andreas Asimakos1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece. silverakos@gmail.com.
Stavroula Spetsioti1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; and National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Spyros Mentzelopoulos1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; and National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Ioannis VogiatzisSport, Exercise and Rehabilitation, University of Northumbria at Newcastle, Newcastle upon Tyne, United Kingdom.
Alice G Vassiliou1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece; and GP Livanos and M Simou Laboratories, Athens, Greece.
Pantelis Gounopoulos2nd Cardiology Department, Evangelismos General Hospital, Athens, Greece.
Archontoula Antonoglou1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; and National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Dimitrios Spaggoulakis1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; and National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Sofia PappaDepartment of Brain Sciences, Faculty of Medicine, Imperial College, London, United Kingdom.
Spyros Zakynthinos1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; and National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Ioanna Dimopoulou1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; and National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Paraskevi Katsaounou1st Department of Critical Care and Pulmonary Services, Evangelismos General Hospital, Athens, Greece; and National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-COVID-19 syndrome has affected millions of people, with rehabilitation being at the center of non-pharmacologic care. However, numerous published studies show conflicting results due to, among other factors, considerable variation in subject characteristics. Currently, the effects of age, sex, time of implementation, and prior disease severity on the outcomes of a supervised rehabilitation program after COVID-19 remain unknown.

methodsThis was a non-randomized case-control study. Subjects with post-COVID-19 sequelae were enrolled. Among study participants, those who could attend an 8-week, supervised rehabilitation program composed the intervention group, whereas those who couldn't the control group. Measurements were collected at baseline and 8 weeks thereafter.

resultsStudy groups (

conclusionsIn this non-randomized, case-control study, post-COVID-19 rehabilitation was associated with improvements in physical function, activity, HRQOL, respiratory symptoms, fatigue, and cognitive impairment. These associations were observed independently of timing of rehabilitation, age, sex, prior hospitalization, and ICU admission.

Indexed as

COVID-19Quality of LifeAgedCase-Control StudiesFatigueFemaleHumansMaleMiddle AgedPost-Acute COVID-19 SyndromeSARS-CoV-2Treatment OutcomeWalk Test6-min walk test (6MWT)fatiguehealth-related quality of life (HRQOL)mental healthphysical functionpost–COVID-19 syndromepulmonary rehabilitationrespiratory symptoms

Identifiers

PMID39043423
PMCPMC11549631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.